Amneal has taken a major step to further expand its business outside of its home US market by striking a “long-term license agreement” with Finland’s Orion to market “a number of Amneal’s complex generic products” in Europe, Australia and New Zealand.
The deal will see Orion become “Amneal’s exclusive partner to bring its portfolio of complex generic programs to most parts...





